AKRO Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.94%

Insider Buying (Last 12 Months): $9,600,000.00

Insider Selling (Last 12 Months): $32,658,485.95

Akero Therapeutics Insider Trading History Chart

Akero Therapeutics Share Price & Price History

^$44.86

▼ -0.99 (-2.16%)

As of 03/13/2025 05:00 PM ET

Days: 30 | 90 | 365

Akero Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/10/2025	Andrew Cheng	CEO	Sell	30,000	$41.77	$1,253,100.00	656,062
3/5/2025	Timothy Rolph	Insider	Sell	12,500	$44.53	$556,625.00	170,237
3/4/2025	Jonathan Young	COO	Sell	50,000	$44.86	$2,243,000.00	201,147
3/3/2025	Patrick Lamy	VP	Sell	1,000	$48.09	$48,090.00	33,492
2/18/2025	Catriona Yale	Insider	Sell	10,000	$49.87	$498,700.00	95,648
2/10/2025	Andrew Cheng	CEO	Sell	30,000	$52.73	$1,581,900.00	686,062
2/5/2025	Timothy Rolph	Insider	Sell	18,750	$56.51	$1,059,562.50	170,237
2/3/2025	Jonathan Young	COO	Sell	10,000	$53.81	$538,100.00	251,147
1/30/2025	G. Walmsley Graham	Director	Buy	200,000	$48.00	$9,600,000.00	1,000,000
1/27/2025	Andrew Cheng	CEO	Sell	30,000	$54.90	$1,647,000.00	716,062
1/27/2025	Patrick Lamy	VP	Sell	5,000	$57.03	$285,150.00	33,492
1/27/2025	Timothy Rolph	Insider	Sell	31,250	$55.77	$1,742,812.50	170,237
1/2/2025	Jonathan Young	COO	Sell	10,000	$28.03	$280,300.00	218,083
12/16/2024	Catriona Yale	Insider	Sell	9,074	$29.11	$264,144.14	95,648
12/16/2024	Patrick Lamy	VP	Sell	1,000	$29.13	$29,130.00	34,258
12/10/2024	Andrew Cheng	CEO	Sell	7,855	$30.79	$241,855.45	597,562
12/10/2024	Jonathan Young	COO	Sell	2,503	$30.79	$77,067.37	203,783
12/10/2024	Patrick Lamy	VP	Sell	925	$30.79	$28,480.75	17,858
12/10/2024	Timothy Rolph	Insider	Sell	4,818	$30.91	$148,924.38	178,337
12/10/2024	William Richard White	CFO	Sell	2,817	$30.79	$86,735.43	38,335
12/2/2024	Andrew Cheng	CEO	Sell	25,000	$32.09	$802,250.00	605,417
12/2/2024	Jonathan Young	COO	Sell	10,000	$32.13	$321,300.00	206,286
11/15/2024	Catriona Yale	Insider	Sell	9,061	$27.73	$251,261.53	74,158
11/1/2024	Andrew Cheng	CEO	Sell	108,366	$31.73	$3,438,453.18	605,417
11/1/2024	Catriona Yale	Insider	Sell	15,485	$32.62	$505,120.70	74,158
11/1/2024	Jonathan Young	COO	Sell	50,716	$31.57	$1,601,104.12	216,286
10/30/2024	Catriona Yale	Insider	Sell	4,515	$32.53	$146,872.95	74,158
10/18/2024	Andrew Cheng	CEO	Sell	63,539	$31.53	$2,003,384.67	605,417
10/16/2024	Andrew Cheng	CEO	Sell	24,992	$31.14	$778,250.88	605,417
10/14/2024	Catriona Yale	Insider	Sell	6,136	$30.03	$184,264.08	74,158
10/14/2024	Jonathan Young	COO	Sell	40,000	$30.15	$1,206,000.00	226,286
10/1/2024	Jonathan Young	COO	Sell	10,000	$28.18	$281,800.00	226,286
9/20/2024	Catriona Yale	Insider	Sell	5,500	$27.65	$152,075.00	75,294
9/18/2024	Catriona Yale	Insider	Sell	3,871	$27.56	$106,684.76	75,294
9/16/2024	Catriona Yale	Insider	Sell	2,485	$27.52	$68,387.20	75,294
9/10/2024	Andrew Cheng	CEO	Sell	1,738	$26.18	$45,500.84	605,417
9/10/2024	Catriona Yale	Insider	Sell	637	$26.18	$16,676.66	75,294
9/10/2024	Jonathan Young	COO	Sell	568	$26.18	$14,870.24	236,286
9/10/2024	William Richard White	CFO	Sell	639	$26.18	$16,729.02	41,152
8/26/2024	Catriona Yale	Insider	Sell	5,200	$27.51	$143,052.00	75,931
8/26/2024	William Richard White	CFO	Sell	75,159	$27.21	$2,045,076.39	41,791
8/23/2024	Catriona Yale	Insider	Sell	8,851	$27.53	$243,668.03	75,931
8/1/2024	Jonathan Young	COO	Sell	5,000	$26.75	$133,750.00	241,854
7/24/2024	William Richard White	CFO	Sell	139,083	$26.98	$3,752,459.34	41,791
7/16/2024	William Richard White	CFO	Sell	34,811	$28.04	$976,100.44	41,791
7/1/2024	Jonathan Young	COO	Sell	5,000	$23.40	$117,000.00	246,854
6/11/2024	Andrew Cheng	CEO	Sell	7,894	$22.64	$178,720.16	581,553
6/11/2024	Catriona Yale	Insider	Sell	2,825	$22.64	$63,958.00	74,867
6/11/2024	Jonathan Young	COO	Sell	2,516	$22.64	$56,962.24	250,790
6/11/2024	Patrick Lamy	VP	Sell	569	$22.64	$12,882.16	18,562
6/11/2024	William Richard White	CFO	Sell	2,831	$22.64	$64,093.84	46,799
6/3/2024	Jonathan Young	COO	Sell	5,000	$19.29	$96,450.00	253,306
5/1/2024	Jonathan Young	COO	Sell	5,000	$20.15	$100,750.00	258,306
4/1/2024	Jonathan Young	COO	Sell	5,000	$24.38	$121,900.00	263,306
3/4/2024	Andrew Cheng	CEO	Sell	75,000	$32.87	$2,465,250.00	591,416
3/4/2024	Catriona Yale	Insider	Sell	20,646	$35.49	$732,726.54	78,415
12/27/2023	Jonathan Young	COO	Sell	5,414	$24.00	$129,936.00	185,131
12/14/2023	Andrew Cheng	CEO	Sell	1,628	$20.76	$33,797.28	550,911
12/14/2023	Catriona Yale	Insider	Sell	597	$20.76	$12,393.72	77,910
12/14/2023	Jonathan Young	COO	Sell	543	$20.76	$11,272.68	185,131
12/14/2023	William Richard White	CFO	Sell	611	$20.76	$12,684.36	50,354
12/11/2023	Andrew Cheng	CEO	Sell	7,405	$20.02	$148,248.10	552,539
12/8/2023	Andrew Cheng	CEO	Sell	12,873	$20.01	$257,588.73	460,998
12/8/2023	G. Walmsley Graham	Director	Buy	100,000	$19.83	$1,983,000.00	800,000
11/30/2023	G. Walmsley Graham	Director	Buy	50,000	$16.90	$845,000.00	650,000
11/17/2023	Jonathan Young	COO	Sell	30,000	$14.68	$440,400.00	153,177
10/2/2023	Andrew Cheng	CEO	Sell	25,000	$47.91	$1,197,750.00	460,998
10/2/2023	Jonathan Young	COO	Sell	490	$51.10	$25,039.00	183,177
9/21/2023	Catriona Yale	Insider	Sell	5,000	$48.07	$240,350.00	46,010
9/13/2023	Andrew Cheng	CEO	Sell	1,682	$50.34	$84,671.88	460,998
9/13/2023	Catriona Yale	Insider	Sell	617	$50.34	$31,059.78	46,010
9/13/2023	Jonathan Young	COO	Sell	562	$50.34	$28,291.08	183,177
9/13/2023	William Richard White	CFO	Sell	632	$50.34	$31,814.88	18,468
9/1/2023	Andrew Cheng	CEO	Sell	25,000	$49.77	$1,244,250.00	462,680
8/28/2023	Catriona Yale	Insider	Sell	5,745	$49.99	$287,192.55	46,627
8/8/2023	G. Walmsley Graham	Director	Buy	25,000	$42.06	$1,051,500.00	600,000
8/1/2023	G. Walmsley Graham	Director	Buy	25,000	$43.26	$1,081,500.00	575,000
7/28/2023	G. Walmsley Graham	Director	Buy	30,000	$42.69	$1,280,700.00	550,000
7/3/2023	Andrew Cheng	CEO	Sell	25,000	$44.88	$1,122,000.00	447,680
6/23/2023	Catriona Yale	Insider	Sell	11,000	$50.76	$558,360.00	46,627
6/21/2023	Catriona Yale	Insider	Sell	11,349	$52.26	$593,098.74	68,627
6/20/2023	William Richard White	CFO	Sell	20,777	$55.00	$1,142,735.00	19,100
6/16/2023	Timothy Rolph	Insider	Sell	78,200	$54.78	$4,283,796.00	151,220
6/16/2023	Tomas J. Heyman	Director	Sell	26,000	$54.67	$1,421,420.00
6/13/2023	Andrew Cheng	CEO	Sell	1,613	$55.16	$88,973.08	407,680
6/13/2023	Jonathan Young	COO	Sell	538	$55.16	$29,676.08	183,739
6/13/2023	Timothy Rolph	Insider	Sell	509	$55.16	$28,076.44	189,420
6/13/2023	William Richard White	CFO	Sell	606	$55.16	$33,426.96	22,377
6/1/2023	Andrew Cheng	CEO	Sell	25,000	$45.10	$1,127,500.00	409,293
5/19/2023	G. Walmsley Graham	Director	Buy	120,000	$42.00	$5,040,000.00	520,000
5/1/2023	Andrew Cheng	CEO	Sell	25,000	$45.07	$1,126,750.00	409,293
4/3/2023	Andrew Cheng	CEO	Sell	25,000	$37.94	$948,500.00	369,293
3/1/2023	Andrew Cheng	CEO	Sell	25,000	$46.65	$1,166,250.00	370,999
2/1/2023	Andrew Cheng	CEO	Sell	25,000	$49.06	$1,226,500.00	370,999
1/13/2023	Catriona Yale	Insider	Sell	5,000	$50.53	$252,650.00	81,268
1/3/2023	Andrew Cheng	CEO	Sell	25,000	$51.27	$1,281,750.00	370,999
1/3/2023	Jonathan Young	COO	Sell	8,777	$54.64	$479,575.28	184,911
12/28/2022	Timothy Rolph	Insider	Sell	1,700	$50.00	$85,000.00	203,032
12/28/2022	William Richard White	CFO	Sell	999	$49.76	$49,710.24	23,624
12/27/2022	Jonathan Young	COO	Sell	12,500	$49.57	$619,625.00	182,449
12/12/2022	Catriona Yale	Insider	Sell	5,000	$43.23	$216,150.00	86,268
12/1/2022	Andrew Cheng	CEO	Sell	10,000	$46.07	$460,700.00	310,148
12/1/2022	Skorpios Trust	Major Shareholder	Sell	1,636,000	$43.50	$71,166,000.00	3,271,829
11/30/2022	Seth Loring Harrison	Director	Sell	11,101	$46.94	$521,080.94	136,301
11/15/2022	Timothy Rolph	Insider	Sell	3,138	$45.04	$141,335.52	187,784
11/10/2022	Catriona Yale	Insider	Sell	5,000	$39.42	$197,100.00	72,073
11/1/2022	Andrew Cheng	CEO	Sell	10,000	$43.42	$434,200.00	310,148
10/27/2022	Seth Loring Harrison	Director	Sell	66,426	$41.53	$2,758,671.78	168,540
10/25/2022	Jonathan Young	COO	Sell	12,500	$44.72	$559,000.00	163,254
10/25/2022	Seth Loring Harrison	Director	Sell	4,515	$44.92	$202,813.80	300,851
10/25/2022	Timothy Rolph	Insider	Sell	10,653	$45.09	$480,343.77	195,684
10/13/2022	William Richard White	CFO	Sell	20,000	$39.82	$796,400.00	4,429
10/10/2022	Catriona Yale	Insider	Sell	5,000	$37.99	$189,950.00	77,073
10/6/2022	Timothy Rolph	Insider	Sell	22,500	$39.29	$884,025.00	186,337
10/3/2022	Andrew Cheng	CEO	Sell	10,000	$33.23	$332,300.00	310,148
9/30/2022	Timothy Rolph	Insider	Sell	45,000	$32.72	$1,472,400.00	198,837
9/13/2022	Andrew Cheng	CEO	Sell	60,000	$27.42	$1,645,200.00	310,148
9/13/2022	Catriona Yale	Insider	Sell	40,000	$27.48	$1,099,200.00	82,073
9/13/2022	William Richard White	CFO	Sell	32,500	$27.03	$878,475.00	4,429

See Full Table

SEC Filings (Institutional Ownership Changes) for Akero Therapeutics (NASDAQ:AKRO)

Institutional Buying and Selling by Quarter

Akero Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/19/2025	GF Fund Management CO. LTD.	1,466	$41K	0.0%	N/A	0.002%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	71,451	$1.99M	0.0%	+18.3%	0.102%
2/17/2025	Woodline Partners LP	379,967	$10.57M	0.1%	+29.9%	0.544%
2/17/2025	Two Sigma Advisers LP	41,100	$1.14M	0.0%	+195.7%	0.059%
2/17/2025	Two Sigma Investments LP	127,320	$3.54M	0.0%	+43.3%	0.182%
2/17/2025	Tema Etfs LLC	32,150	$0.89M	0.4%	N/A	0.046%
2/17/2025	RTW Investments LP	6,859,823	$190.84M	2.9%	+15.9%	9.828%
2/17/2025	Rafferty Asset Management LLC	72,604	$2.02M	0.0%	-19.7%	0.104%
2/17/2025	Redmile Group LLC	1,235,209	$34.36M	2.4%	-11.0%	1.770%
2/17/2025	Point72 Asia Singapore Pte. Ltd.	2,848	$79K	0.0%	-69.1%	0.004%
2/17/2025	Point72 Asset Management L.P.	899,680	$25.03M	0.1%	-31.0%	1.289%
2/17/2025	ProShare Advisors LLC	22,398	$0.62M	0.0%	+32.4%	0.032%
2/17/2025	MPM Bioimpact LLC	460,617	$12.81M	1.8%	+17.3%	0.660%
2/17/2025	Nuveen Asset Management LLC	171,518	$4.77M	0.0%	-1.9%	0.246%
2/17/2025	Orbimed Advisors LLC	66,000	$1.84M	0.0%	N/A	0.095%
2/17/2025	Millennium Management LLC	16,736	$0.47M	0.0%	-77.6%	0.024%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	41,442	$1.15M	0.0%	+1.6%	0.059%
2/17/2025	Janus Henderson Group PLC	6,034,239	$167.77M	0.1%	-14.7%	8.645%
2/17/2025	Fred Alger Management LLC	263,353	$7.33M	0.0%	-2.3%	0.377%
2/17/2025	D. E. Shaw & Co. Inc.	35,809	$1M	0.0%	-71.4%	0.051%
2/17/2025	Deutsche Bank AG	273,811	$7.62M	0.0%	-18.4%	0.392%
2/17/2025	Deep Track Capital LP	1,490,000	$41.45M	1.5%	+116.0%	2.135%
2/17/2025	Cubist Systematic Strategies LLC	30,208	$0.84M	0.0%	N/A	0.043%
2/17/2025	Cutter Capital Management LP	230,000	$6.40M	2.6%	N/A	0.330%
2/17/2025	Brevan Howard Capital Management LP	9,879	$0.28M	0.0%	-30.7%	0.014%
2/17/2025	Balyasny Asset Management L.P.	649,134	$18.06M	0.0%	N/A	0.930%
2/17/2025	Bank of America Corp DE	66,264	$1.84M	0.0%	-58.5%	0.095%
2/17/2025	BNP Paribas Financial Markets	8,482	$0.24M	0.0%	-59.0%	0.012%
2/17/2025	Ameriprise Financial Inc.	15,172	$0.42M	0.0%	N/A	0.022%
2/17/2025	Algert Global LLC	59,734	$1.66M	0.0%	-12.2%	0.086%
2/17/2025	Alkeon Capital Management LLC	1,761,268	$49M	0.1%	-47.0%	2.523%
2/17/2025	5AM Venture Management LLC	165,000	$4.59M	1.1%	N/A	0.236%
2/14/2025	PDT Partners LLC	137,030	$3.81M	0.3%	-1.6%	0.196%
2/14/2025	Schonfeld Strategic Advisors LLC	262,295	$7.30M	0.0%	-5.8%	0.376%
2/14/2025	Emerald Mutual Fund Advisers Trust	352,180	$9.80M	0.6%	-15.2%	0.505%
2/14/2025	Foresite Capital Management VI LLC	365,000	$10.15M	4.5%	N/A	0.523%
2/14/2025	Northern Trust Corp	620,321	$17.26M	0.0%	+6.1%	0.889%
2/14/2025	The Manufacturers Life Insurance Company	124,592	$3.47M	0.0%	+29.0%	0.178%
2/14/2025	Quarry LP	3,000	$83K	0.0%	N/A	0.004%
2/14/2025	Aquatic Capital Management LLC	18,041	$0.50M	0.0%	+463.8%	0.026%
2/14/2025	Susquehanna Fundamental Investments LLC	8,390	$0.23M	0.0%	N/A	0.012%
2/14/2025	Virtus ETF Advisers LLC	2,449	$68K	0.0%	-34.5%	0.004%
2/14/2025	Voya Investment Management LLC	20,471	$0.57M	0.0%	-7.1%	0.029%
2/14/2025	T. Rowe Price Investment Management Inc.	670,048	$18.64M	0.0%	-48.5%	0.960%
2/14/2025	Price T Rowe Associates Inc. MD	4,321,972	$120.24M	0.0%	+13.5%	6.192%
2/14/2025	Dark Forest Capital Management LP	16,893	$0.47M	0.1%	N/A	0.024%
2/14/2025	Hsbc Holdings PLC	7,886	$0.22M	0.0%	+8.5%	0.011%
2/14/2025	Rock Springs Capital Management LP	946,499	$26.33M	1.0%	+1.4%	1.356%
2/14/2025	B Group Inc.	260,000	$7.23M	4.4%	N/A	0.372%
2/14/2025	Tower Research Capital LLC TRC	16,188	$0.45M	0.0%	+770.8%	0.023%
2/14/2025	MetLife Investment Management LLC	41,565	$1.16M	0.0%	+5.9%	0.060%
2/14/2025	Dimensional Fund Advisors LP	449,110	$12.50M	0.0%	+6,229.1%	0.643%
2/13/2025	Marshall Wace LLP	275,074	$7.65M	0.0%	N/A	0.394%
2/13/2025	Jump Financial LLC	15,854	$0.44M	0.0%	-71.8%	0.023%
2/13/2025	Walleye Capital LLC	134,705	$3.75M	0.0%	N/A	0.193%
2/13/2025	Barclays PLC	132,837	$3.70M	0.0%	+4.0%	0.190%
2/13/2025	Summit Investment Advisors Inc.	7,092	$0.20M	0.2%	+6.8%	0.010%
2/13/2025	University of Wisconsin Foundation	410,630	$11.42M	8.3%	-3.1%	0.588%
2/13/2025	Optimize Financial Inc	8,336	$0.23M	0.2%	N/A	0.012%
2/13/2025	Sterling Capital Management LLC	1,789	$50K	0.0%	+764.3%	0.003%
2/13/2025	F M Investments LLC	45,778	$1.27M	0.0%	N/A	0.066%
2/13/2025	Renaissance Technologies LLC	20,800	$0.58M	0.0%	N/A	0.030%
2/13/2025	Legal & General Group Plc	50,080	$1.39M	0.0%	-9.9%	0.072%
2/13/2025	Invesco Ltd.	98,463	$2.74M	0.0%	+27.3%	0.141%
2/13/2025	Springhill Fund Asset Management HK Co Ltd	151,200	$4.21M	6.8%	N/A	0.217%
2/13/2025	Envestnet Asset Management Inc.	10,164	$0.28M	0.0%	-5.1%	0.015%
2/13/2025	Wells Fargo & Company MN	61,867	$1.72M	0.0%	+14.0%	0.089%
2/12/2025	ExodusPoint Capital Management LP	55,207	$1.54M	0.0%	+15.9%	0.079%
2/12/2025	Cinctive Capital Management LP	67,964	$1.89M	0.1%	+4.1%	0.097%
2/12/2025	Headlands Technologies LLC	2,035	$57K	0.0%	-69.5%	0.003%
2/12/2025	Geode Capital Management LLC	1,559,631	$43.40M	0.0%	-0.7%	2.234%
2/12/2025	Alliancebernstein L.P.	1,839,281	$51.17M	0.0%	-8.8%	2.635%
2/12/2025	Wellington Management Group LLP	7,376,961	$205.23M	0.0%	-6.6%	10.569%
2/12/2025	Schroder Investment Management Group	25,615	$0.72M	0.0%	-86.1%	0.037%
2/12/2025	NEOS Investment Management LLC	32,150	$0.89M	0.0%	-25.4%	0.046%
2/12/2025	JPMorgan Chase & Co.	528,207	$14.70M	0.0%	+8.2%	0.757%
2/11/2025	Corebridge Financial Inc.	33,706	$0.94M	0.0%	-7.0%	0.048%
2/11/2025	Emerald Advisers LLC	520,114	$14.47M	0.6%	-0.8%	0.745%
2/11/2025	Vanguard Group Inc.	3,704,411	$103.06M	0.0%	+0.8%	5.307%
2/11/2025	Simplify Asset Management Inc.	264,677	$7.36M	0.4%	-6.7%	0.379%
2/11/2025	KLP Kapitalforvaltning AS	11,000	$0.31M	0.0%	N/A	0.016%
2/11/2025	Sei Investments Co.	10,887	$0.30M	0.0%	N/A	0.016%
2/11/2025	American Century Companies Inc.	112,442	$3.13M	0.0%	+55.1%	0.161%
2/11/2025	Yiheng Capital Management L.P.	666,145	$18.53M	0.7%	-12.2%	0.954%
2/11/2025	Teacher Retirement System of Texas	14,415	$0.40M	0.0%	+18.7%	0.021%
2/11/2025	Intech Investment Management LLC	37,902	$1.05M	0.0%	+121.6%	0.054%
2/10/2025	Kennondale Capital Management LLC	28,217	$0.79M	0.6%	N/A	0.040%
2/10/2025	Swiss National Bank	95,600	$2.66M	0.0%	+1.2%	0.137%
2/10/2025	Great Lakes Advisors LLC	193,384	$5.38M	0.0%	N/A	0.277%
2/7/2025	AlphaQuest LLC	8,172	$0.23M	0.0%	+32,588.0%	0.012%
2/6/2025	Proficio Capital Partners LLC	11,490	$0.32M	0.0%	N/A	0.016%
2/6/2025	Charles Schwab Investment Management Inc.	540,692	$15.04M	0.0%	+1.5%	0.775%
2/5/2025	Proficio Capital Partners LLC	11,490	$0.32M	0.0%	N/A	0.016%
2/4/2025	Bank of New York Mellon Corp	200,430	$5.58M	0.0%	-3.1%	0.287%
2/4/2025	Y Intercept Hong Kong Ltd	8,950	$0.25M	0.0%	-47.1%	0.013%
2/3/2025	Handelsbanken Fonder AB	21,000	$0.58M	0.0%	+5.0%	0.030%
1/31/2025	Global Retirement Partners LLC	4,917	$0.14M	0.0%	-13.1%	0.007%
1/30/2025	Rhumbline Advisers	105,686	$2.94M	0.0%	+1.3%	0.151%
1/24/2025	abrdn plc	269,782	$7.51M	0.0%	+118.7%	0.387%
1/24/2025	China Universal Asset Management Co. Ltd.	14,800	$0.41M	0.0%	+10.8%	0.021%

Data available starting January 2016

See Full Table

Akero Therapeutics, Inc., together with its subsidiary, engages in the development of treatments for patients with serious metabolic diseases in the United States. The company's lead product candidate is efruxifermin (EFX), which is in Phase 3 clinical trials that protects against cellular stress and regulates the metabolism of lipids, carbohydrates, and proteins throughout the body for the treatment of biopsy-confirmed metabolic dysfunction-associated steatohepatitis (MASH) patients. It has a license agreement with Amgen Inc. to develop, manufacture, use, distribute, and sell EFX as a treatment for MASH and other metabolic diseases. The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.

Today's Range

Now: $44.86

$43.71

$45.95

50 Day Range

MA: $41.78

$21.87

$57.56

52 Week Range

Now: $44.86

$17.86

$58.40

Volume

591,949 shs

Average Volume

840,735 shs

Market Capitalization

$3.57 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Akero Therapeutics?: Akero Therapeutics' top insider shareholders include:
G Walmsley Graham (Director)
Andrew Cheng (CEO)
Jonathan Young (COO)
Timothy Rolph (Insider)
Catriona Yale (Insider)
William Richard White (CFO)
Patrick Lamy (VP)
Tomas J Heyman (Director)
Learn More about top insider investors at Akero Therapeutics.
Who are the major institutional investors of Akero Therapeutics?: Akero Therapeutics' top institutional investors include:
Wellington Management Group LLP — 10.57%
RTW Investments LP — 9.83%
Janus Henderson Group PLC — 8.65%
Price T Rowe Associates Inc. MD — 6.19%
Vanguard Group Inc. — 5.31%
Alliancebernstein L.P. — 2.64%
Learn More about top institutional investors of Akero Therapeutics stock.
Which institutional investors are selling Akero Therapeutics stock?: In the last quarter, AKRO stock was sold by these institutional investors:
Alkeon Capital Management LLC
Janus Henderson Group PLC
T. Rowe Price Investment Management Inc.
Wellington Management Group LLP
Point72 Asset Management L.P.
Alliancebernstein L.P.
Schroder Investment Management Group
Redmile Group LLC
In the previous year, company insiders that have sold Akero Therapeutics company stock include:
G Walmsley Graham (Director)
Andrew Cheng (CEO)
Jonathan Young (COO)
Timothy Rolph (Insider)
Catriona Yale (Insider)
William Richard White (CFO)
Learn More investors selling Akero Therapeutics stock.
Which institutional investors are buying Akero Therapeutics stock?: During the last quarter, AKRO stock was purchased by institutional investors including:
RTW Investments LP
Deep Track Capital LP
Balyasny Asset Management L.P.
SG Americas Securities LLC
Price T Rowe Associates Inc. MD
Dimensional Fund Advisors LP
Foresite Capital Management VI LLC
Marshall Wace LLP